feed,title,long_url,short_url
Benzinga,"The Daily Biotech Pulse: Biohaven, Bristol-Myers Squibb Snag FDA Approvals, Iterum UTI Drug Review On Track, Centessa Pharmaceuticals Debuts On Nasdaq",https://benzinga.com/general/biotech/21/05/21336344/the-daily-biotech-pulse-biohaven-bristol-myers-squibb-snag-fda-approvals-iterum-uti-drug-review-o,https://j.mp/3hWqQc0
Benzinga,Biohaven's Nurtec Wins FDA Approval As First Med to Prevent and Treat Migraine Attacks,https://benzinga.com/general/biotech/21/05/21334962/biohavens-nurtec-wins-fda-approval-as-first-med-to-prevent-and-treat-migraine-attacks,https://j.mp/3oWMIWh
Benzinga,Multiple Miners Make Their Way In for Q1 OTC Market Index Rebalancing,https://benzinga.com/news/21/05/21337042/multiple-miners-make-their-way-in-for-q1-otc-market-index-rebalancing,https://j.mp/3oWscVJ
